Ketan R. Patel stands as the current Chairman & Managing Director of Troikaa Pharmaceuticals Limited, a company established in 1983 in Ahmedabad, Gujarat, by Rajni V. Patel. Rajni V. Patel was among the first pharmacy graduates from L. M. College of Pharmacy, Ahmedabad, in 1950. Ketan Patel has earned the moniker "India’s pain killer" for his role in inventing the world's first painless diclofenac injection, a significant advancement in alleviating acute pain and inflammation.
Troikaa Pharmaceuticals: A Legacy of Innovation
Troikaa Pharmaceuticals Limited has grown since its inception to become a prominent player in the pharmaceutical industry. The company boasts three manufacturing facilities located in Gujarat and Uttarakhand, all of which are certified by ISO 9001:2000 and WHO GMP (The World Health Organization for following Good Manufacturing Practices). With six marketing divisions and a workforce exceeding 2300 employees, Troikaa has a substantial presence in the market.
Manufacturing and Certifications
The company's commitment to quality is evident in its adherence to international standards. The ISO 9001:2000 certification reflects Troikaa's dedication to maintaining a robust quality management system. The WHO GMP certification underscores its compliance with Good Manufacturing Practices, ensuring the safety and efficacy of its pharmaceutical products.
Key Innovations and Products
Troikaa Pharmaceuticals has been at the forefront of pharmaceutical innovation, particularly in developing novel drug delivery systems.
Dynapar QPS
Dynapar QPS is one of Troikaa's flagship products. The company has secured patents for Dynapar AQ in various regions, including Australia and the CIS countries. Troikaa also commenced work on a Sanand plant to manufacture Dynapar.
Read also: Understanding Doctor Profiles
Painless Diclofenac Injection
Ketan Patel's invention of the world's first painless diclofenac injection is a testament to his innovative spirit. This breakthrough has provided a more comfortable and effective option for patients requiring pain relief.
Controversies and Legal Challenges
Despite its successes, Troikaa Pharmaceuticals has faced its share of controversies and legal challenges.
Diclofenac Sodium Injection Concerns
Troikaa Pharmaceuticals once claimed that the diclofenac sodium 75 mg/ml injection contained Transcutol-P, which caused damage to the kidneys.
Design Infringement Suit
In 2008, Troikaa filed a suit for infringement of design against a company manufacturing D’ shaped tablets. The company had challenged that Troikaa's D-shaped tablet registration was invalid.
Awards and Recognition
Troikaa Pharmaceuticals has received several awards and recognitions for its contributions to the pharmaceutical industry and its commitment to innovation. These accolades include:
Read also: Ketan: An Indian name explained
- National Award for Dynapar QPS.
- Recognition from the Government of India.
- Award for IP Excellence.
- IPA-ACG innovation in Solid Dosage form Award.
Other ventures
Specialty Homeopathy
Dr. Ketan Patel is described as a dynamic personality who has been practicing homoeopathy.
Other controversies
Bitcoin extortion case
A total of 14 people, including the then police inspector (PI) Anant Patel, former BJP MLA Nalin Kotadiya, ex-Amreli SP Jagdish Patel, and a lawyer, have been named as accused in the sensational 2018 kidnapping and bitcoin extortion case involving Surat-based builder Shailesh Bhatt. As per the case details, Bhatt was allegedly kidnapped by PI Anant Patel and his team using government vehicles. The accused took him near Gandhinagar and allegedly forced him to transfer 176 bitcoins worth around ₹9 crore. Following this, CID arrested Jagdish Patel as well and continued further probe.